Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.

Saved in:
Bibliographic Details
Title: Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for Locally Advanced Pancreatic Adenocarcinoma: Randomized, Open-Label, Pivotal Phase III PANOVA-3 Study.
Authors: Babiker HM; Mayo Clinic, Jacksonville, FL., Picozzi V; Virginia Mason Medical Center, Seattle, WA., Chandana SR; The Cancer & Hematology Centers, Grand Rapids, MI., Melichar B; Palacky University and University Hospital Olomouc, Olomouc, Czech Republic., Kasi A; University of Kansas Cancer Center, Kansas City, KS., Gang J; Changhai Hospital, Shanghai, People's Republic of China., Gallego J; General University Hospital Elche, Elche, Spain., Bullock A; Harvard Medical School, Harvard University, Boston, MA.; Beth Israel Deaconess Medical Center, Boston, MA., Chunyi H; Beijing Cancer Hospital, Beijing, People's Republic of China., Wyrwicz L; National Institute of Oncology, Maria Sklodowska Curie National Cancer Research Institute, Warsaw, Poland., Hitre E; National Institute of Oncology, Budapest, Hungary., Osipov A; Cedars-Sinai Medical Center, Los Angeles, CA., de la Fouchardiere C; Centre Léon Bérard, Lyon, France., Ales I; University Hospital Malaga, Malaga, Spain., Dragovich T; Baptist MD Anderson Cancer Center, Jacksonville, FL., Lee W; National Cancer Center, Goyang, Republic of Korea., Feeney K; St John of God Murdoch Hospital, Murdoch, WA, Australia., Philip P; Henry Ford Hospital, Detroit, MI., Ueno M; Kanagawa Cancer Center, Yokohama, Japan., Van Cutsem E; University of Leuven, Leuven, Belgium., Seufferlein T; Ulm University Hospital, Ulm, Germany., Macarulla T; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
Corporate Authors: PANOVA-3 Study Investigators
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2025 Jul 20; Vol. 43 (21), pp. 2350-2360. Date of Electronic Publication: 2025 May 31.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study; Research Support, N.I.H., Extramural
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO-25-00746